Publication | Open Access

Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab

MedicinePrognostic ValueColorectal CancerPathologyImmune Checkpoint InhibitorChemotherapy Plus BevacizumabCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentTumor Biology